| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.118 | 43.359 | 53.521 | 69.269 | 68.799 | 68.575 | 73.343 | 89.009 | 92.973 |
| Total Income - EUR | - | 7.118 | 43.379 | 53.541 | 69.277 | 68.900 | 68.576 | 73.365 | 89.068 | 92.994 |
| Total Expenses - EUR | - | 3.641 | 21.894 | 26.523 | 32.136 | 37.382 | 38.207 | 43.547 | 58.896 | 62.184 |
| Gross Profit/Loss - EUR | - | 3.477 | 21.486 | 27.018 | 37.141 | 31.518 | 30.369 | 29.818 | 30.172 | 30.810 |
| Net Profit/Loss - EUR | - | 3.406 | 21.052 | 26.485 | 36.448 | 30.893 | 29.697 | 29.173 | 29.389 | 28.431 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Dr. Sava Toader Viorica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 647 | 410 | 206 | 97 | 42.908 | 0 | 22.108 | 16.311 | 10.520 |
| Current Assets | - | 4.240 | 22.033 | 20.817 | 38.582 | 17.915 | 31.630 | 24.159 | 24.343 | 21.179 |
| Inventories | - | 0 | 33 | 334 | 336 | 333 | 339 | 353 | 12 | 13 |
| Receivables | - | 3.146 | 4.095 | 4.866 | 8.797 | 8.705 | 6.708 | 6.920 | 15.247 | 16.570 |
| Cash | - | 1.094 | 17.905 | 15.617 | 29.449 | 8.876 | 24.583 | 16.886 | 9.084 | 4.596 |
| Shareholders Funds | - | 3.450 | 21.160 | 19.320 | 36.494 | 58.496 | 29.821 | 29.378 | 30.375 | 28.481 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.437 | 1.283 | 1.703 | 2.185 | 2.326 | 1.808 | 16.890 | 10.279 | 3.219 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Sava Toader Viorica Srl